By extension, future research should address the mechanistic role that COX-2/PGE2 axis plays in melanoma biology and determining if pharmacological inhibition of COX-2 could prevent cancer stem cell survival, EMT and metastasis. This evidence concerns the gene PTGS2 and cancer.